{"SPADE_UN_17679": {"Clinical Information": [], "Patent Information": [{"Patent No": "US20020086420A1", "Patent Link": "http://www.lens.org/lens/patent/US20020086420A1", "Patent Type": "Granted Patent", "Publication Date": "2002-7-4", "Family Info": "Notavailable", "Patent Title": "Novel antiangiogenic peptides", "Abstract": "The present invention provides an antiangiogenic polypeptide having the amino acid sequence set forth in SEQ ID NO: 1 or a portion thereof which is effective to inhibit endothelial cell proliferation as determined by the capillary EC proliferation assay. Preferably, the portion has at least 50% inhibition of bFGF-stimulated EC proliferation at 5 Tg/ml, more preferably 75% inhibition, most preferably 95% inhibition."}], "Sequence Information": {"SPADE ID": "SPADE_UN_17679", "Sequence": "KITRCPMIPC", "Sequence Length": 10, "Peptide Name": "aa 129-138; partial loop-4+loop-5", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Frequent Amino Acids": "CIP", "Absent Amino Acids": "ADEFGHLNOQSUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 5, "Positive Residues": 2, "Negative Residues": 0, "Mass": 1161.5, "PI": 8.96, "Net Charge": 2, "Hydrophobicity": 0.36, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02431", "Similarity": 1.0, "Sequence": "ILQKAVLDCLKAAGSSLSKAAITAIYNKIT"}, {"SPADE_ID": "SPADE_N_09398", "Similarity": 1.0, "Sequence": "LPVVFKIASKVVPSVISKIT"}, {"SPADE_ID": "SPADE_UN_02454", "Similarity": 1.0, "Sequence": "WRITIIKIT"}]}}}